Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Interest Expenses (2019 - 2025)

Biodesix (BDSX) has disclosed Interest Expenses for 7 consecutive years, with $2.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Interest Expenses rose 17.52% year-over-year to $2.1 million, compared with a TTM value of $7.7 million through Dec 2025, down 6.56%, and an annual FY2025 reading of $7.7 million, down 6.56% over the prior year.
  • Interest Expenses was $2.1 million for Q4 2025 at Biodesix, down from $2.1 million in the prior quarter.
  • Across five years, Interest Expenses topped out at $3.0 million in Q3 2022 and bottomed at $651000.0 in Q1 2021.
  • Average Interest Expenses over 5 years is $1.9 million, with a median of $2.0 million recorded in 2024.
  • Peak annual rise in Interest Expenses hit 112.2% in 2021, while the deepest fall reached 70.73% in 2021.
  • Year by year, Interest Expenses stood at $1.5 million in 2021, then skyrocketed by 70.45% to $2.6 million in 2022, then fell by 8.67% to $2.3 million in 2023, then dropped by 24.77% to $1.8 million in 2024, then increased by 17.52% to $2.1 million in 2025.
  • Business Quant data shows Interest Expenses for BDSX at $2.1 million in Q4 2025, $2.1 million in Q3 2025, and $1.9 million in Q2 2025.